Kiriyakides, member of the European Commission in charge of health and food safety, said yesterday (25th) that AstraZeneca’s plan to reduce the number of vaccine deliveries is “unacceptable” and that the European Commission will set up a transparent mechanism for vaccine exports.
On Friday, AstraZeneca said it intends to reduce the supply of vaccine in the next few weeks, significantly less than the dose previously agreed and announced, which is unacceptable to the European Union, kiriakidis said. She has written to AstraZeneca to emphasize the importance of complying with the agreed delivery schedule.
Recently, both AstraZeneca and Pfizer said they would reduce vaccine supply in the short term on the grounds of the need to expand production capacity. In this regard, many EU countries expressed dissatisfaction. European Council President Michelle said the European Union would urge pharmaceutical companies to abide by the contracts signed before, and that all measures should be taken to ensure timely supply of vaccines if necessary.
At present, the European Union has approved two new crown vaccines to be put on the market conditionally. One is the vaccine jointly developed by Pfizer and German biotechnology company, and the other is the vaccine developed by American Modena company.